Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandros Rampotas

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pathology|October 17, 2020
Platelet aggregates, a marker of severe COVID-19 diseaseAlexandros Rampotas, Sue Pavord
Blood|September 24, 2024
The present and future of CAR T-cell therapy for adult B-cell ALLAlexandros Rampotas, Claire Roddie
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2024
Choosing the right double-barreled gun: ARI0003 takes aim at lymphoma by targeting both CD19 and BCMAAlexandros Rampotas, Isaac Gannon, Claire Roddie
Therapeutic Advances in Hematology|November 4, 2021
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphomaAlexandros Rampotas, Gina Sangha, Graham P Collins
Best Practice & Research. Clinical Haematology|November 4, 2022
Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approachAlexandros Rampotas, Rupen Hargreaves, Donal P McLornan
Transfusion Medicine (Oxford, England)|May 31, 2021
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approachAlexandros Rampotas, Catherine F Prodger, Michael F Murphy
Bone Marrow Transplantation|October 8, 2024
CAR-T cell therapy embarks on autoimmune diseaseAlexandros Rampotas, Johanna Richter, David Isenberg, et al.
Expert Review of Hematology|May 28, 2022
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse eventsEdmund Watson, Faouzi Djebbari, Alexandros Rampotas, et al.
The Lancet. Haematology|November 7, 2024
Accelerating and optimising CAR T-cell manufacture to deliver better patient productsGiulia Agliardi, Juliana Dias, Alexandros Rampotas, et al.
British Journal of Haematology|August 1, 2023
Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?Dina Mahdi, Jessica Spiers, Alexandros Rampotas, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pathology|October 17, 2020
Platelet aggregates, a marker of severe COVID-19 diseaseAlexandros Rampotas, Sue Pavord
Blood|September 24, 2024
The present and future of CAR T-cell therapy for adult B-cell ALLAlexandros Rampotas, Claire Roddie
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 21, 2024
Choosing the right double-barreled gun: ARI0003 takes aim at lymphoma by targeting both CD19 and BCMAAlexandros Rampotas, Isaac Gannon, Claire Roddie
Therapeutic Advances in Hematology|November 4, 2021
Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphomaAlexandros Rampotas, Gina Sangha, Graham P Collins
Best Practice & Research. Clinical Haematology|November 4, 2022
Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approachAlexandros Rampotas, Rupen Hargreaves, Donal P McLornan
Transfusion Medicine (Oxford, England)|May 31, 2021
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approachAlexandros Rampotas, Catherine F Prodger, Michael F Murphy
Bone Marrow Transplantation|October 8, 2024
CAR-T cell therapy embarks on autoimmune diseaseAlexandros Rampotas, Johanna Richter, David Isenberg, et al.
Expert Review of Hematology|May 28, 2022
BCMA-targeted therapies for multiple myeloma: strategies to maximize efficacy and minimize adverse eventsEdmund Watson, Faouzi Djebbari, Alexandros Rampotas, et al.
The Lancet. Haematology|November 7, 2024
Accelerating and optimising CAR T-cell manufacture to deliver better patient productsGiulia Agliardi, Juliana Dias, Alexandros Rampotas, et al.
British Journal of Haematology|August 1, 2023
Updates on accelerated and blast phase myeloproliferative neoplasms: Are we making progress?Dina Mahdi, Jessica Spiers, Alexandros Rampotas, et al.
Pageof 4